title: Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis?
abstract: The study aimed to determine the prevalence of HBs-Ag and anti-HCV antibodies in a group of 43 patients with lichen planus and 19 patients with cutaneous vasculitis versus 30 controls. The results showed that 12 (27.9%) patients with lichen planus were positive for HBs-Ag, 9 (20.9%) were positive for anti-HCV antibodies and 3 (7%) were positive for both. In cutaneous vasculitis patients, 3 (15.8%) were HBs-Ag-positive, 7 (36.8%) were anti-HCV-positive and 3 (15.8%) were positive for both. In the control group, 8 (26.7%) were HBs-Ag positive, 3 (10%) were anti-HCV-positive and 1 (3.3%) was positive for both. These values were not statistically significant.
authors.affiliation: Department of Dermatology, Alexandria University, Egypt.
authors.forename: H A
authors.initials: HA
authors.lastname: Ibrahim
authors.forename: M M
authors.initials: MM
authors.lastname: Baddour
authors.forename: M G
authors.initials: MG
authors.lastname: Morsi
authors.forename: A A
authors.initials: AA
authors.lastname: Abdelkader
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D016022:Case-Control Studies; D002648:Child; D015897:Comorbidity; D004534:Egypt / Q000453:epidemiology; D005260:Female; D006509:Hepatitis B / Q000097:blood / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D006514:Hepatitis B Surface Antigens / Q000097:blood; D006526:Hepatitis C / Q000097:blood / Q000150:complications* / Q000453:epidemiology / Q000276:immunology; D018937:Hepatitis C Antibodies / Q000097:blood; D006785:Hospitals, University; D006801:Humans; D008010:Lichen Planus / Q000150:complications* / Q000453:epidemiology; D008297:Male; D008403:Mass Screening / Q000379:methods*; D008875:Middle Aged; D018579:Patient Selection; D016036:Seroepidemiologic Studies; D018366:Vasculitis, Leukocytoclastic, Cutaneous / Q000150:complications* / Q000453:epidemiology
chemical_list: D006514:Hepatitis B Surface Antigens; D018937:Hepatitis C Antibodies